BYRN vs UTHR · P/E 18, rev $16.4M vs P/E 20, rev $1.56B
Byrna Technologies Inc (BYRN) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Byrna Technologies Inc (BYRN) is a aerospace & defense company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported BYRN revenue for 2026-05-31 was $16.4M. Net income was -$10.1M. Revenue was down 43.6% from 2026-02-28 to 2026-05-31. BYRN currently screens at market cap $148.6M and trailing P/E 18.2.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
BYRN currently screens at market cap $148.6M and trailing P/E 18.2. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the BYRN and UTHR stock pages for the full models.
Not investment advice.